Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Scotet

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody productionNadia Caccamo, Luca Battistini, Marc Bonneville, et al.
Cancers|April 3, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft ModelMarisa Capitao, Justine Perrin, Sylvain Simon, et al.
Oncoimmunology|November 18, 2016
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemiaAudrey Benyamine, Aude Le Roy, Emilie Mamessier, et al.
Clinical Immunology (Orlando, Fla.)|March 23, 2015
Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cellsFamke L Schneiders, Charlotte M Huijts, Aslihan Mantici, et al.
Cancer Immunology Research|June 18, 2014
CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosisFamke L Schneiders, Jan Prodöhl, Jurjen M Ruben, et al.
Oncotarget|March 17, 2018
Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantationChristelle Retière, Catherine Willem, Thierry Guillaume, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma CellsCynthia Chauvin, Noémie Joalland, Jeanne Perroteau, et al.
Immunity|January 25, 2005
Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-IEmmanuel Scotet, Laurent O Martinez, Ethan Grant, et al.
Clinical Immunology (Orlando, Fla.)|November 30, 2011
Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-αFamke L Schneiders, Renée C G de Bruin, Saskia J A M Santegoets, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2017
Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2Romain Marlin, Angela Pappalardo, Hannah Kaminski, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody productionNadia Caccamo, Luca Battistini, Marc Bonneville, et al.
Cancers|April 3, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft ModelMarisa Capitao, Justine Perrin, Sylvain Simon, et al.
Oncoimmunology|November 18, 2016
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemiaAudrey Benyamine, Aude Le Roy, Emilie Mamessier, et al.
Clinical Immunology (Orlando, Fla.)|March 23, 2015
Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cellsFamke L Schneiders, Charlotte M Huijts, Aslihan Mantici, et al.
Cancer Immunology Research|June 18, 2014
CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosisFamke L Schneiders, Jan Prodöhl, Jurjen M Ruben, et al.
Oncotarget|March 17, 2018
Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantationChristelle Retière, Catherine Willem, Thierry Guillaume, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma CellsCynthia Chauvin, Noémie Joalland, Jeanne Perroteau, et al.
Immunity|January 25, 2005
Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-IEmmanuel Scotet, Laurent O Martinez, Ethan Grant, et al.
Clinical Immunology (Orlando, Fla.)|November 30, 2011
Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-αFamke L Schneiders, Renée C G de Bruin, Saskia J A M Santegoets, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2017
Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2Romain Marlin, Angela Pappalardo, Hannah Kaminski, et al.
Pageof 7